MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

94.28 +1.12 (+1.20%)
Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Analyst Ratings For Zimmer Biomet Holdings ↗
Over the past 3 months, 7 analysts have published their opinion on Zimmer Biomet Holdings (NYSE: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2022 ↗
Upgrades According to Vertical Research, the prior rating for Livent Corp (NYSE: 
Via Benzinga
News headline image
Expert Ratings For Zimmer Biomet Holdings ↗
Over the past 3 months, 7 analysts have published their opinion on Zimmer Biomet Holdings (NYSE: 
Via Benzinga
News headline image
Expert Ratings For Zimmer Biomet Holdings ↗
Over the past 3 months, 4 analysts have published their opinion on Zimmer Biomet Holdings (NYSE: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 ↗
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: 
Via Benzinga
News headline image
2 Medical Device Stocks Wall Street Predicts Will Rally 35% Or More ↗
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. 
Via Talk Markets
Analyzing Zimmer Biomet Holdings's Unusual Options Activity ↗
On Tuesday, shares of Zimmer Biomet Holdings (NYSE:ZBH) saw ... 
Via Benzinga
News headline image
Recap: Zimmer Biomet Q2 Earnings ↗
Shares of Zimmer Biomet Holdings (NYSE:ZBH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 3700.00% over the past year... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021 ↗
Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ: 
Via Benzinga
News headline image
7 F-Rated Dividend Stocks You Shouldn’t Get Suckered Into ↗
As dividend stocks, these companies aren’t worth a second glance, even though some boast tempting dividend yields. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021 ↗
Upgrades For CarMax Inc (NYSE: 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Friday ↗
Wedbush raised Uber Technologies, Inc. (NYSE:UBER)... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021 ↗
Upgrades Keefe, Bruyette & Woods upgraded the previous rating for CBRE Group Inc (NYSE: 
Via Benzinga
News headline image
Zimmer Biomet Holdings Inc (ZBH) Q3 2021 Earnings Call Transcript ↗
ZBH earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Zimmer Biomet Shares Hit After Lowering Annual Guidance ↗
Zimmer Biomet Holdings Inc's (NYSE: ZBH) Q3 sales decreased marginally by 0.3% Y/Y to $1.92 billion (down 0.8% on a constant currency basis), missing the... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
News headline image
Price Over Earnings Overview: Zimmer Biomet Holdings ↗
Looking into the current session, Zimmer Biomet Holdings Inc. (NYSE:ZBH) is trading at $145.73, after a 0.1% decrease. Over the past month, the stock fell by 0.64%,... 
Via Benzinga
News headline image
Software Error Prompts Zimmer Biomet To Recall Rosa One Robotic Neurosurgery Platform ↗
Zimmer Biomet Holdings Inc (NYSE: ZBH) is facing a Class I recall of its Rosa One Brain platform. Devices ranging from biopsy needles to endoscopes to deep brain... 
Via Benzinga
Topics Product Recall
News headline image
Zimmer Biomet Scores FDA De Novo Nod For Smart Knee Implant ↗
Zimmer Biomet Holdings Inc (NYSE: ZBH) and Canary Medical have announced that the FDA granted de novo classification for Persona IQ. The de novo grant... 
Via Benzinga
News headline image
FDA Approves Zimmer Biomet's Rosa Hip Personalized Robotic System ↗
Zimmer Biomet Holdings Inc (NYSE: ZBH) has received FDA 510(k) clearance for its Rosa Hip system for robotically-assisted surgery. The system is designed for... 
Via Benzinga
News headline image
Zimmer Biomet Holdings Inc (ZBH) Q2 2021 Earnings Call Transcript ↗
ZBH earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Zimmer Biomet Stock Falls After Lowering Bottom End Of FY21 Outlook; Q2 Earnings Beat ↗
Zimmer Biomet Holdings Inc (NYSE: ZBH) posted Q2 adjusted EPS of $1.90, ahead of the consensus of $1.87 and higher than $0.05 posted a year ago. It reported a profit of... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
News headline image
Earnings Scheduled For August 3, 2021 ↗
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to... 
Via Benzinga
News headline image
A Look Into Zimmer Biomet's Price Over Earnings ↗
Looking into the current session, Zimmer Biomet Holdings Inc. (NYSE:ZBH) is trading at $162.42, after a 0.20% drop. Over the past month, the stock decreased by 0.68... 
Via Benzinga
News headline image
This Part of the Reopening Trade Is Just Getting Started ↗
As hospitals address the major backlog of pandemic-postponed elective surgeries, medical device makers -- and their stock prices -- could benefit. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 ↗
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
News headline image
1 More Excellent Reason to Love This Leading Healthcare Company ↗
As elective surgery candidates return to operating rooms, revenue will ramp up. 
Via The Motley Fool
News headline image
Zimmer Biomet Holdings Inc (ZBH) Q1 2021 Earnings Call Transcript ↗
ZBH earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Zimmer Biomet Stock Dips Despite Q1 Earnings Beat, Better-Than-Expected Guidance ↗
Zimmer Biomet Holdings Inc (NYSE: ZBH) shares took a hit today despite first-quarter results beating the consensus. Adjusted diluted EPS of $1.71, grew 0.6% Y... 
Via Benzinga
Topics Earnings
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story